Related Experiment Videos

[Clinical features and etiological spectrum in children with pancytopenia]

Jun Wu1, Yi-Fei Cheng, Le-Ping Zhang

  • 1Department of Pediatrics, People's Hospital, Peking University, Beijing, China.

Zhongguo Dang Dai Er Ke Za Zhi = Chinese Journal of Contemporary Pediatrics
|September 20, 2011
PubMed

Insights

Pediatric pancytopenia commonly presents with anemia, bleeding, and fever. Aplastic anemia is the leading cause, followed by myelodysplastic syndrome and hematological tumors.

Area of Science:

  • Hematology
  • Pediatric Medicine
  • Clinical Research

Context:

  • Pancytopenia in children presents unique diagnostic challenges.
  • Understanding the etiological spectrum is crucial for effective management.
  • This study reviews clinical features and causes in a pediatric cohort.

Purpose:

  • To investigate the clinical manifestations of pancytopenia in children.
  • To determine the etiological spectrum of pediatric pancytopenia.
  • To identify common causes and associated symptoms.

Summary:

  • Retrospective analysis of 174 children with pancytopenia revealed anemia, bleeding, and fever as primary symptoms.
  • Hematopoietic system diseases accounted for 89.1% of cases, with aplastic anemia (52.3%) being the most frequent diagnosis.
  • Myelodysplastic syndrome (21.3%), acute leukemia/tumors (6.3%), and hemophagocytic syndrome (3.4%) were also significant causes.

Impact:

  • Highlights aplastic anemia as the predominant cause of pediatric pancytopenia.
  • Provides insights into the clinical presentation and etiological landscape.
  • Informs diagnostic and therapeutic strategies for childhood pancytopenia.
Abstract

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...